Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Urologic Oncology: Seminars and Original Investigations | Oct 08, 2017
Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Oct 04, 2017
Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis
Nutrition, Metabolism & Cardiovascular Diseases | Oct 01, 2017
|Most read this week